ArticleAdvanced materials (Deerfield Beach, Fla.)2026
Electrically Modulated Semi-Convertible Hydrogel Microneedles for Programmable Insulin Delivery.
Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Insulin delivery systems that mimic pancreatic secretion offer promising improvements in type 1 diabetes management. However, current systems struggle with sustained and precise release. Inspired by the dynamic secretion mechanisms of the pancreas, a wearable electrically modulated semi-convertible hydrogel microneedle system for insulin delivery has been developed for long-term self-regulation in the treatment of type 1 diabetes. This system combines a non-covalent electro-responsive silk fibroin network and a polyethylene glycol/chitosan matrix, integrated with flexible electrodes that exhibit a partial gel-sol phase transition under 1.2 V electrical stimulation. In hyperglycemic conditions, the electric field induces silk fibroin phase transition, triggering insulin release through electrostatic interactions and polymer network expansion. Once blood glucose normalizes, insulin is released passively via diffusion when the electric field is turned off. In type 1 diabetic mice, a single microneedle patch provides segmented control, with a 10-min stimulation effect lasting up to 8 h, extendable to 16 h with further stimulation. This system offers a versatile, sustained, and precise drug delivery strategy with significant potential for chronic disease management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.